Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Lynn Morris

Showing results (131-140 of 324) with videos related to

Pageof 33
Sort By:
Viruses|April 3, 2021
Infection of Chinese Rhesus Monkeys with a Subtype C SHIV Resulted in Attenuated In Vivo Viral Replication Despite Successful Animal-to-Animal Serial PassagesGerald K Chege, Craig H Adams, Alana T Keyser, et al.
The American Journal of Cardiology|August 7, 2025
Variations in Management and Outcomes of Pulmonary Embolism in Uninsured Compared With Privately Insured IndividualsMridul Bansal, Aryan Mehta, Ghanshyam Ps Shantha, et al.
AIDS (London, England)|May 11, 2010
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South AfricaZiad El-Khatib, Anna Mia Ekstrom, Johanna Ledwaba, et al.
AIDS (London, England)|June 27, 2008
Early virological suppression with three-class antiretroviral therapy in HIV-infected African infantsAndrew Prendergast, Wendy Mphatswe, Gareth Tudor-Williams, et al.
The Journal of Infectious Diseases|August 15, 2013
Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switchVictoria Johnston, Karen Cohen, Lubbe Wiesner, et al.
Plos Pathogens|November 9, 2013
Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypesConstantinos Kurt Wibmer, Jinal N Bhiman, Elin S Gray, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapineAdriaan E Basson, Matshediso Ntsala, Neil Martinson, et al.
Molecular Biology and Evolution|February 3, 2007
A model of directional selection applied to the evolution of drug resistance in HIV-1Cathal Seoighe, Farahnaz Ketwaroo, Visva Pillay, et al.
Virology|August 22, 2009
Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolatesAshika Singh, Taryn Page, Penny L Moore, et al.
Journal of Virology|June 24, 2011
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding siteKabamba Bankoledi Alexandre, Elin S Gray, Ralph Pantophlet, et al.
Pageof 33

Showing results (131-140 of 324) with videos related to

Sort By:
Pageof 33
Viruses|April 3, 2021
Infection of Chinese Rhesus Monkeys with a Subtype C SHIV Resulted in Attenuated In Vivo Viral Replication Despite Successful Animal-to-Animal Serial PassagesGerald K Chege, Craig H Adams, Alana T Keyser, et al.
The American Journal of Cardiology|August 7, 2025
Variations in Management and Outcomes of Pulmonary Embolism in Uninsured Compared With Privately Insured IndividualsMridul Bansal, Aryan Mehta, Ghanshyam Ps Shantha, et al.
AIDS (London, England)|May 11, 2010
Viremia and drug resistance among HIV-1 patients on antiretroviral treatment: a cross-sectional study in Soweto, South AfricaZiad El-Khatib, Anna Mia Ekstrom, Johanna Ledwaba, et al.
AIDS (London, England)|June 27, 2008
Early virological suppression with three-class antiretroviral therapy in HIV-infected African infantsAndrew Prendergast, Wendy Mphatswe, Gareth Tudor-Williams, et al.
The Journal of Infectious Diseases|August 15, 2013
Viral suppression following switch to second-line antiretroviral therapy: associations with nucleoside reverse transcriptase inhibitor resistance and subtherapeutic drug concentrations prior to switchVictoria Johnston, Karen Cohen, Lubbe Wiesner, et al.
Plos Pathogens|November 9, 2013
Viral escape from HIV-1 neutralizing antibodies drives increased plasma neutralization breadth through sequential recognition of multiple epitopes and immunotypesConstantinos Kurt Wibmer, Jinal N Bhiman, Elin S Gray, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 8, 2008
Development of phenotypic HIV-1 drug resistance after exposure to single-dose nevirapineAdriaan E Basson, Matshediso Ntsala, Neil Martinson, et al.
Molecular Biology and Evolution|February 3, 2007
A model of directional selection applied to the evolution of drug resistance in HIV-1Cathal Seoighe, Farahnaz Ketwaroo, Visva Pillay, et al.
Virology|August 22, 2009
Functional and genetic analysis of coreceptor usage by dualtropic HIV-1 subtype C isolatesAshika Singh, Taryn Page, Penny L Moore, et al.
Journal of Virology|June 24, 2011
Binding of the mannose-specific lectin, griffithsin, to HIV-1 gp120 exposes the CD4-binding siteKabamba Bankoledi Alexandre, Elin S Gray, Ralph Pantophlet, et al.
Pageof 33